ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 72 filers reported holding ALBIREO PHARMA INC in Q1 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $311,000 | -61.1% | 16,061 | -37.3% | 0.00% | 0.0% |
| Q3 2021 | $799,000 | +30.1% | 25,601 | +46.7% | 0.00% | 0.0% |
| Q2 2021 | $614,000 | +146.6% | 17,457 | +147.3% | 0.00% | +100.0% |
| Q1 2021 | $249,000 | -21.0% | 7,058 | -25.3% | 0.00% | -75.0% |
| Q3 2020 | $315,000 | +21.2% | 9,448 | -3.7% | 0.00% | 0.0% |
| Q2 2020 | $260,000 | -53.6% | 9,810 | -55.4% | 0.00% | +33.3% |
| Q4 2019 | $560,000 | +26.1% | 22,017 | -0.9% | 0.00% | -25.0% |
| Q3 2019 | $444,000 | +83.5% | 22,217 | +195.6% | 0.00% | +100.0% |
| Q2 2019 | $242,000 | – | 7,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 174,791 | $6,556,000 | 3.03% |
| Sio Capital Management, LLC | 354,210 | $13,286,000 | 2.72% |
| Birchview Capital, LP | 92,000 | $3,451,000 | 1.99% |
| Chicago Capital, LLC | 618,263 | $23,191,000 | 1.04% |
| Perceptive Advisors | 2,360,139 | $88,529,000 | 0.95% |
| Endurant Capital Management LP | 42,292 | $1,586,000 | 0.57% |
| Artal Group S.A. | 700,000 | $26,257,000 | 0.56% |
| Cormorant Asset Management, LP | 500,000 | $18,755,000 | 0.45% |
| Samsara BioCapital, LLC | 100,000 | $3,751,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 257,372 | $9,654,000 | 0.34% |